| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-1.4B | $0.3B | $0.1B | $0.5B | $0.6B | $0.8B | $0.4B | $0.4B |
| EPS (Basic) | $-8.44 | $1.80 | $0.54 | $3.18 | $3.83 | $3.26 | $1.75 | $-0.30 |
| EPS (Diluted) | $-8.44 | $1.80 | $0.54 | $3.18 | $3.82 | $3.26 | $1.74 | $-0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.1B | $37.5B | $36.8B | $35.5B | $30.2B | $22.8B | $18.4B | $14.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.6B | $0.6B | $0.8B | $0.4B | $0.6B | $0.2B | $0.2B |
| Total Liabilities | $14.9B | $15.1B | $14.1B | $12.8B | $11.2B | $9.4B | $8.2B | $6.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $15.5B | $17.9B | $18.5B | $19.0B | $16.2B | $11.7B | $8.9B | $7.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.5B | $1.6B | $1.3B | $1.0B | $0.9B | $0.7B | $0.6B |
| Investing Cash Flow | $0.4B | $-1.5B | $-2.5B | $-5.1B | $-7.1B | $-3.3B | $-3.6B | $-2.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.8B | $-0.1B | $0.7B | $4.2B | $5.9B | $2.8B | $2.9B | $1.6B |